News
News
PublISHED ON
UpDATED ON
Sweden participates in clinical WHO study
Sweden is participating in a major clinical study conducted by WHO, aimed at testing a number of antiviral medicines on patients around the world who are being treated for COVID-19.
Because more than 100 countries are taking part in the WHO study Solidarity Trial, the patient base is large. This makes it quicker to see whether any of the preparations are effective, and can begin to be used to treat the disease.
The Swedish Government recently appointed Soo Aleman, Consultant Physician at the Karolinska University Hospital and Associate Professor at Karolinska Institutet, to be the national coordinator for the Swedish part of the study. The Swedish Research Council will fund Swedish participation, as soon as the investment is formalized in the regulatory letter.
“It is important for Sweden to be part of the international study. Patients in Sweden who have suffered severe COVID-19 can now get access to potentially effective medicines. In the long term we will obtain greater knowledge of what is effective, which will also benefit patients who are not part of the study,” says Jan-Ingvar Jönsson, Secretary General of the Scientific Council for Medicine and Health and Clinical Therapy Research at the Swedish Research Council.
About the studie Solidarity trial on WHO´s website
External link.
RELATERAT INNEHÅLL
MORE WITHIN THE SAME SUBJECT AREA
-
News |
Published 13 February 2025
In April, we will open four calls for proposals, in addition to those previously announced for 2025.
-
News |
Published 30 December 2024
This year, the Swedish Research Council received around 5 800 applications for research grants. 860 of these were awarded funding. In total, 4.55 billion SEK has been awarded to research at Swedish higher education institutions, and 2.81 billion SEK ...
-
News |
Published 17 December 2024
The elector council has now appointed new members of the Swedish Research Council’s board and scientific councils for the period 2025–2027. The mandate period is three years, and members may be reappointed for a further three-year period.